The AFIB is primarily focused on research for and attention on patients, as present in their theme for this year's meeting: 'Biomedical engineering, a universe of expertise at the service of the patient'. In a healthcare industry in the midst of transformation, biomedical engineering supports healthcare institutions in a technological evolution necessary to improve patient care.
This will be the 22nd Biomedical Engineering meeting, and is the largest congress of biomedical hospital engineering in France, taking place at the Palais des Congres in Dijon.
If you are interested in meeting with our Sales and Marketing Director, please contact us at contact@goldstandardphantoms.com, or stop by our booth (exact location to be confirmed) for a warm welcome.
Website: http://www.afib2017.fr/
GSP are excited to be attending the National Radiology Conference 2017 in Linköping, Sweden. We will be based on a booth (positioned in the Startup Area) ready to meet and greet anyone interested in discussing our technology and endeavours.
This year's conference will be arranged by the Department of Radiology at Linköping University Hospital together with CMIV, Center for Medical Image Science and Visualization, in close cooperation with the Swedish Society for Radiology and the Swedish Society for Radiographers.
The site for the venue is Linköping Concert & Congress Hall, situated in the heart of Linköping. This year’s theme is Integrated Diagnostics and the Conference will describe how radiology interacts with other disciplines within health care, as well as how important it is that we all participate in the development of integrated diagnostics.
In addition to many interesting presentations, it is a great opportunity for GSP to integrate with industry professionals through meetings and social events, to shares ideas and discuss the future of radiology, particularly in medical devices.
If you or your colleagues would like to arrange a meeting with our Sales and Marketing Director, Laurent Morin, please contact us at contact@goldstandardphantoms.com, where we would be very happy to arrange an appointment, or provide further information regarding our first product, QASPER.
Website : http://rontgenveckan.se/
Gold Standard Phantoms secured an additional £840k in private investment.
Gold Standard Phantoms are happy to announce that it has secured an additional £840,000 in private investment, in order to bring its first product to market and establish itself as a key provider of calibration services for clinical quantitative medical imaging worldwide.
GSP was founded in 2014 with the aim of providing a solution to the issue of calibration and quality assurance in quantitative medical imaging. It was the receiver of the prestigious Small Business Research Initiative Healthcare's Phase I and Phase II awards in 2015 and 2016 for a total of £1.1 million, which enabled it to bring its first product, an imaging standard for Arterial Spin Labelling Perfusion MRI, from early stage prototype through to commercial product. It has also, together with the National Physical Laboratory and NEL, been awarded a £170,000 project from Innovate UK’s 'Analysis for Innovators' competition to create a 'traceable calibration for an MRI perfusion measurement'.
GSP's first product, QASPER, is an advanced calibration phantom for Arterial Spin Labelling (ASL). Its features include a unique MRI-compatible pump design, the use of proprietary technology to simulate capillary blood flow, and is calibrated to international standards.
ASL is a magnetic resonance imaging technique for measuring tissue perfusion using a freely diffusible intrinsic tracer. ASL is non-invasive in nature and offers the ability to quantitatively measure tissue perfusion, which makes this method ideal for research and clinical studies. Recent technical advances have increased its sensitivity and extended its potential applications; it is now available for routine clinical practice in many institutions.
Quantitative Medical Imaging is not yet a clinical reality. Despite wide acceptance in research, intrinsically quantitative methods such as ASL are still not used in daily clinical practice due to the lack of internationally recognised standards and governance to enable quality assurance of quantitative data. As such, our first product will provide the enabling step to make the clinical use of quantitative ASL possible.
With this investment, Gold Standard Phantoms welcomes Frédéric Schenk, Group Vice President at SGS, and Riccardo Pavoncelli of Augmenta Capital to GSP's Board of Directors.
